Medical Marijuana Card for ALS (Lou Gehrig's Disease)

ALS appears on nearly every state qualifying list, and many states fast-track or extend allowances for ALS patients given the disease's trajectory.

Schedule Your Evaluation

Nothing in the cannabis literature alters ALS progression — the evidence grade is insufficient for disease modification, and riluzole/edaravone conversations belong with your neurologist. The certification rationale is symptom burden: spasticity and cramps (where the MS-derived cannabinoid evidence plausibly transfers), drooling (THC's dry-mouth side effect, repurposed), appetite, sleep, and anxiety.

Practical access matters disproportionately: most states' telehealth rules, caregiver provisions, and (in several states) terminal-illness accommodations exist for exactly this situation. Utah waives its in-person requirement for patients who can't travel; many states allow caregiver purchasing from day one — your state page lists specifics.

The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law.

FAQ

ALS (Lou Gehrig's Disease) questions

Can cannabis slow ALS?

No evidence supports that. Honest use targets comfort — spasticity, cramps, secretions, sleep, appetite — alongside your neurology team's care.

What if I can't attend appointments?

Telehealth covers most states; several offer homebound/terminal exceptions to in-person rules (Utah explicitly), and caregiver registration handles purchasing. The logistics are more solvable than most families expect.

Which states accept als (lou gehrig's disease) for a medical marijuana card?

Most programs cover it: 21 states list als (lou gehrig's disease) explicitly — including Alaska, Arizona, Arkansas, Connecticut, Florida — and 8 more use physician-discretion standards where a doctor can certify it case by case.

Medical sources & references

NASEM 2017 — ALS Evidence — National Academies, 2017.Insufficient evidence for cannabis altering ALS outcomes; symptom-management rationale only
NCCIH — Cannabis and Cannabinoids Overview — NIH / NCCIH, 2019.NIH evidence framework for neurological symptom management
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research — National Academies of Sciences, Engineering, and Medicine, 2017.Comprehensive evidence review underpinning condition-level statements
Cannabis (Marijuana) and Cannabinoids: What You Need To Know — National Center for Complementary and Integrative Health, NIH, 2019.NIH evidence summaries by condition

This page summarizes the cited evidence reviews; it does not make treatment claims beyond them. Discuss your specific situation with a licensed physician.

Talk to a doctor about als (lou gehrig's disease)

A licensed physician will tell you honestly whether you qualify — and you pay nothing if you don't.

Schedule Your Evaluation